{
  "id": "cluster_3_doc2",
  "content": "Insurance memo dated 2023-05-15 outlines new coverage guidelines for protracted Lyme disease treatments. Policy REF: NW-4763B mandates pre-authorization for IV antibiotics beyond 28 days in Spokane-area clinics. Memo references research study NCT04587611 on long-term outcomes and cost-effectiveness. Implementation team contact: lyme.coordinator@nw.ins.net, phone 509-345-2121 ext. 475.",
  "metadata": {
    "format": "insurance_memo"
  }
}